{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:52:29Z","timestamp":1791417149707,"version":"4.3.3"},"reference-count":41,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100009102","name":"Education Department of Jiangxi Province","doi-asserted-by":"publisher","award":["GJJ2200110"],"award-info":[{"award-number":["GJJ2200110"]}],"id":[{"id":"10.13039\/501100009102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020205","name":"Health Commission of Jiangxi Province","doi-asserted-by":"publisher","award":["202610023"],"award-info":[{"award-number":["202610023"]}],"id":[{"id":"10.13039\/501100020205","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ejso.2026.112151","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:11:12Z","timestamp":1790035872000},"page":"112151","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Preoperative CT-based radiomics prediction of tertiary lymphoid structures and prognostic integration with pathological microvascular invasion in resectable hepatocellular carcinoma: a multicenter study"],"prefix":"10.1016","volume":"52","author":[{"given":"Yongming","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siya","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenlei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laichang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianjun","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ru","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghui","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianwei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8232-5848","authenticated-orcid":false,"given":"Yufei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2026.112151_bib1","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(18)30010-2","article-title":"Hepatocellular carcinoma","volume":"391","author":"Forner","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ejso.2026.112151_bib2","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1056\/NEJMra1713263","article-title":"Hepatocellular carcinoma","volume":"380","author":"Villanueva","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejso.2026.112151_bib3","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma","volume":"69","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejso.2026.112151_bib4","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jhep.2018.09.003","article-title":"Intra-tumoral tertiary lymphoid structures are associated with a low risk of early recurrence of hepatocellular carcinoma","volume":"70","author":"Calderaro","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejso.2026.112151_bib5","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/s12885-018-4196-x","article-title":"The prognostic value of microvascular invasion in early-intermediate stage hepatocelluar carcinoma: a propensity score matching analysis","volume":"18","author":"Shen","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejso.2026.112151_bib6","doi-asserted-by":"crossref","first-page":"8212","DOI":"10.1097\/JS9.0000000000003045","article-title":"Refining risk stratification in hepatocellular carcinoma by integrating tertiary lymphoid structures and microvascular invasion: a multicenter retrospective study","volume":"111","author":"Ma","year":"2025","journal-title":"Int J Surg"},{"key":"10.1016\/j.ejso.2026.112151_bib7","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41568-019-0144-6","article-title":"Tertiary lymphoid structures in the era of cancer immunotherapy","volume":"19","author":"Saut\u00e8s-Fridman","year":"2019","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ejso.2026.112151_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.574228","article-title":"Radiomic feature-based predictive model for microvascular invasion in patients with hepatocellular carcinoma","volume":"10","author":"He","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.ejso.2026.112151_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2025.111341","article-title":"Multi-phase CT-based intratumoral and peritumoral radiomics for predicting tertiary lymphoid structures of hepatocellular carcinoma: a multi-center retrospective cohort study","volume":"52","author":"Wang","year":"2026","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2026.112151_bib10","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nrclinonc.2017.141","article-title":"Radiomics: the bridge between medical imaging and personalized medicine","volume":"14","author":"Lambin","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.ejso.2026.112151_bib11","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1148\/radiol.2020191470","article-title":"Radiomic features at contrast-enhanced CT predict recurrence in early stage hepatocellular carcinoma: a multi-institutional Study","volume":"294","author":"Ji","year":"2020","journal-title":"Radiology"},{"key":"10.1016\/j.ejso.2026.112151_bib12","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13244-020-00887-2","article-title":"Radiomics in medical imaging-\"how-to\" guide and critical reflection","volume":"11","author":"van Timmeren","year":"2020","journal-title":"Insights Imaging"},{"key":"10.1016\/j.ejso.2026.112151_bib13","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s00330-022-09055-0","article-title":"ITHscore: comprehensive quantification of intra-tumor heterogeneity in NSCLC by multi-scale radiomic features","volume":"33","author":"Li","year":"2023","journal-title":"Eur Radiol"},{"key":"10.1016\/j.ejso.2026.112151_bib14","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ebiom.2019.10.057","article-title":"Machine-learning analysis of contrast-enhanced CT radiomics predicts recurrence of hepatocellular carcinoma after resection: a multi-institutional study","volume":"50","author":"Ji","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ejso.2026.112151_bib15","first-page":"127","article-title":"Artificial intelligence in cancer imaging: clinical challenges and applications","volume":"69","author":"Bi","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ejso.2026.112151_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.labinv.2023.100063","article-title":"Standardized pathology screening of mature tertiary lymphoid structures in cancers","volume":"103","author":"Vanhersecke","year":"2023","journal-title":"Lab Invest"},{"key":"10.1016\/j.ejso.2026.112151_bib17","doi-asserted-by":"crossref","first-page":"246","DOI":"10.21037\/hbsn-24-359","article-title":"Chinese expert consensus on the diagnosis and treatment of hepatocellular carcinoma with microvascular invasion (2024 edition)","volume":"14","author":"Sun","year":"2025","journal-title":"Hepatobiliary Surg Nutr"},{"key":"10.1016\/j.ejso.2026.112151_bib18","doi-asserted-by":"crossref","first-page":"e104","DOI":"10.1158\/0008-5472.CAN-17-0339","article-title":"Computational radiomics system to decode the radiographic phenotype","volume":"77","author":"van Griethuysen","year":"2017","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejso.2026.112151_bib19","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1148\/radiol.2020191145","article-title":"The image biomarker standardization initiative: standardized quantitative radiomics for high-throughput image-based phenotyping","volume":"295","author":"Zwanenburg","year":"2020","journal-title":"Radiology"},{"key":"10.1016\/j.ejso.2026.112151_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmpb.2025.109137","article-title":"Multiperspective tumor heterogeneity metrics for preoperative prediction of IASLC grading in clinical stage IA lung adenocarcinomas: a multicenter study","volume":"274","author":"Zuo","year":"2026","journal-title":"Comput Methods Progr Biomed"},{"key":"10.1016\/j.ejso.2026.112151_bib21","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/s13244-025-02097-0","article-title":"Intratumoral heterogeneity score enhances invasiveness prediction in pulmonary ground-glass nodules via stacking ensemble machine learning","volume":"16","author":"Zuo","year":"2025","journal-title":"Insights Imaging"},{"key":"10.1016\/j.ejso.2026.112151_bib22","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-078378","article-title":"TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods","volume":"385","author":"Collins","year":"2024","journal-title":"Br Med J"},{"key":"10.1016\/j.ejso.2026.112151_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2022.110309","article-title":"Preoperative prediction of intra-tumoral tertiary lymphoid structures based on CT in hepatocellular cancer","volume":"151","author":"Li","year":"2022","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.ejso.2026.112151_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2025.1652509","article-title":"Machine learning-driven prediction of intratumoral tertiary lymphoid structures in hepatocellular carcinoma using contrast-enhanced CT imaging and integrated clinical data","volume":"15","author":"Wu","year":"2025","journal-title":"Front Oncol"},{"key":"10.1016\/j.ejso.2026.112151_bib25","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-011126","article-title":"Transfer learning radiomic model predicts intratumoral tertiary lymphoid structures in hepatocellular carcinoma: a multicenter study","volume":"13","author":"Long","year":"2025","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.ejso.2026.112151_bib26","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.celrep.2018.03.086","article-title":"Spatial organization and molecular correlation of tumor-infiltrating lymphocytes using deep learning on pathology images","volume":"23","author":"Saltz","year":"2018","journal-title":"Cell Rep"},{"key":"10.1016\/j.ejso.2026.112151_bib27","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1038\/s41598-018-20471-5","article-title":"Development of an immune-pathology informed radiomics model for non-small cell lung cancer","volume":"8","author":"Tang","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.ejso.2026.112151_bib28","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/S1470-2045(18)30413-3","article-title":"A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study","volume":"19","author":"Sun","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2026.112151_bib29","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/s41586-019-1914-8","article-title":"Tertiary lymphoid structures improve immunotherapy and survival in melanoma","volume":"577","author":"Cabrita","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ejso.2026.112151_bib30","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.ejso.2026.112151_bib31","article-title":"Targets for immunotherapy of liver cancer","author":"Greten","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejso.2026.112151_bib32","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.immuni.2018.10.005","article-title":"Developmental and functional heterogeneity of monocytes","volume":"49","author":"Guilliams","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.ejso.2026.112151_bib33","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju124","article-title":"Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis","volume":"106","author":"Templeton","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejso.2026.112151_bib34","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/s41586-019-1922-8","article-title":"B cells and tertiary lymphoid structures promote immunotherapy response","volume":"577","author":"Helmink","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ejso.2026.112151_bib35","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1001\/jamasurg.2015.4257","article-title":"Nomogram for preoperative estimation of microvascular invasion risk in hepatitis B virus-related hepatocellular carcinoma within the milan criteria","volume":"151","author":"Lei","year":"2016","journal-title":"JAMA Surg"},{"key":"10.1016\/j.ejso.2026.112151_bib36","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/s43018-021-00232-6","article-title":"Mature tertiary lymphoid structures predict immune checkpoint inhibitor efficacy in solid tumors independently of PD-L1 expression","volume":"2","author":"Vanhersecke","year":"2021","journal-title":"Nat Cancer"},{"key":"10.1016\/j.ejso.2026.112151_bib37","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/nrc.2015.5","article-title":"NK cells and cancer: you can teach innate cells new tricks","volume":"16","author":"Morvan","year":"2016","journal-title":"Nat Rev Cancer"},{"issue":"Suppl 1","key":"10.1016\/j.ejso.2026.112151_bib38","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/hep.31288","article-title":"Epidemiology of hepatocellular carcinoma","volume":"73","author":"McGlynn","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.ejso.2026.112151_bib39","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jhep.2017.05.014","article-title":"Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification","volume":"67","author":"Calderaro","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejso.2026.112151_bib40","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/01.sla.0000197706.21803.a1","article-title":"Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications","volume":"243","author":"Portolani","year":"2006","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2026.112151_bib41","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0168-8278(02)00360-4","article-title":"Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy","volume":"38","author":"Imamura","year":"2003","journal-title":"J Hepatol"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798326007705?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798326007705?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:45:27Z","timestamp":1791416727000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798326007705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":41,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S0748798326007705"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2026.112151","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preoperative CT-based radiomics prediction of tertiary lymphoid structures and prognostic integration with pathological microvascular invasion in resectable hepatocellular carcinoma: a multicenter study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2026.112151","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112151"}}